Summary
- Current Price
- As of today, LKFT price is $29.04, up +0.83% on
- Current Price All-Time High
- LKFT price is currently -89.40% below its historical high of $274.03 set on
- Market Cap
- LKFT current market cap is $2B, down -9.82% year-over-year
- PE Ratio
- LKFT current PE ratio is 2.76
- Revenue
- LKFT current annual revenue is $1.26B, up +320.99% year-over-year
- Next Earnings
- The next earnings release for LKFT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Lakefront Biotherapeutics NV |
| Ticker | NASDAQ: LKFT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Belgium |
| IPO | |
| Indexes | Not included |
| Website | lakefrontbio.com |
| Employees | 452 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $29.04 | |
| Price, 1D Change | +0.83% | |
| $2B | ||
| - | ||
| 2.76 | ||
| 0.56 | ||
| $1.26B | ||
| Revenue, 1Y Change | +320.99% | |
| $5.50 | ||
| EPS, 1Y Change | +351.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | GLPG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $5.50 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $1.26B | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $29.04 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $3.47 | - | |
| - | $1.22 | - | |
| - | $5.50 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $259.17M | - | |
| - | $298.17M | - | |
| - | $1.26B | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $29.04 | |
| $30.50 | ||
| $28.65 | ||
| $29.67 | ||
| $28.38 | ||
| $0.06 | ||
| 0.56 | ||
| $0.83 | ||
| 56.47 | ||
| 51.61% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.26B | ||
| $5.50 | ||
| $1.16B | ||
| 92.66% | ||
| $530.05M | ||
| 42.23% | ||
| $360.57M | ||
| 28.72% | ||
| $588.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 20.11 | ||
| 19.96 | ||
| - | ||
| 6 | ||
| 7.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 2.76 | ||
| 1.65 | ||
| 0.51 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $3.80B | ||
| $3.52B | ||
| $4.00B | ||
| $3.61B | ||
| $200.42M | ||
| $179.53M | ||
| $8.12M | ||
| $2.03M | ||
| $77.19M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $894.69M | ||
| $633.13M | ||
| $92.08M | ||
| $173.16M | ||
| $63.06M | ||
| $0.00 | ||
| -$21.02M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$222.34M | ||
| $257.73M | ||
| -$3.69M | ||
| $15.64M | ||
| -$237.98M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Morgan Stanley | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with LKFT
FAQ
- What is the ticker symbol for Lakefront Biotherapeutics NV?
- The ticker symbol for Lakefront Biotherapeutics NV is NASDAQ:LKFT
- Does Lakefront Biotherapeutics NV pay dividends?
- No, Lakefront Biotherapeutics NV does not pay dividends
- What sector is Lakefront Biotherapeutics NV in?
- Lakefront Biotherapeutics NV is in the Healthcare sector
- What industry is Lakefront Biotherapeutics NV in?
- Lakefront Biotherapeutics NV is in the Biotechnology industry
- What country is Lakefront Biotherapeutics NV based in?
- Lakefront Biotherapeutics NV is headquartered in Belgium
- When did Lakefront Biotherapeutics NV go public?
- Lakefront Biotherapeutics NV initial public offering (IPO) was on May 5, 2005
- Is Lakefront Biotherapeutics NV in the S&P 500?
- No, Lakefront Biotherapeutics NV is not included in the S&P 500 index
- Is Lakefront Biotherapeutics NV in the NASDAQ 100?
- No, Lakefront Biotherapeutics NV is not included in the NASDAQ 100 index
- Is Lakefront Biotherapeutics NV in the Dow Jones?
- No, Lakefront Biotherapeutics NV is not included in the Dow Jones index
- When was Lakefront Biotherapeutics NV last earnings report?
- Lakefront Biotherapeutics NV's most recent earnings report was on August 10, 2026
- When does Lakefront Biotherapeutics NV report earnings?
- The next expected earnings date for Lakefront Biotherapeutics NV is November 12, 2026
Data Sources & References
- LKFT Official Website lakefrontbio.com
- LKFT Profile on Yahoo Finance finance.yahoo.com/quote/LKFT
- LKFT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lkft